Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCB-276 CAR T Cell Therapy for Diffuse Intrinsic Pontine Glioma
NCT07680439Phase 2Recruiting
- Start
- Sep 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of SC-CAR4BRAIN in diffuse intrinsic pontine glioma (DIPG). Primary endpoint: Overall Survival up to 24 months. Started Sep 2026; status: recruiting.
02
Drugs
SC-CAR4BRAIN
03
Conditions
diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT07680439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07680439.